NEW YORK, Sept. 10 - BD Biosciences and the Canadian Network for Vaccines and Immunotherapeutics today said they have teamed up to develop antibodies and immune function assays.
CANVAC, a network of 72 Canadian scientists and their affiliated institutions, will give BD Biosciences exclusive access to its collection of full-length gene clones and proteins. BD Biosciences will use the clones for antibody development, according to the company.
Access to CANVAC's database will be handled by two of its member institutions: the University Health Network based in Toronto and Université de Montréal.